Cargando…
Updates in Diagnosis and Treatment of Acromegaly
Acromegaly is a rare disease, caused largely by a growth hormone (GH) pituitary adenoma. Incidence is higher than previously thought. Due to increased morbidity and mortality, if not appropriately treated, early diagnosis efforts are essential. Screening is recommended for all patients with clinical...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Touch Medical Media
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182922/ https://www.ncbi.nlm.nih.gov/pubmed/30349595 http://dx.doi.org/10.17925/EE.2018.14.2.57 |
_version_ | 1783362668795527168 |
---|---|
author | Zahr, Roula Fleseriu, Maria |
author_facet | Zahr, Roula Fleseriu, Maria |
author_sort | Zahr, Roula |
collection | PubMed |
description | Acromegaly is a rare disease, caused largely by a growth hormone (GH) pituitary adenoma. Incidence is higher than previously thought. Due to increased morbidity and mortality, if not appropriately treated, early diagnosis efforts are essential. Screening is recommended for all patients with clinical features of GH excess. There is increased knowledge that classical diagnostic criteria no longer apply to all, and some patients can have GH excess with normal GH response to glucose. Treatment is multifactorial and personalised therapy is advised. |
format | Online Article Text |
id | pubmed-6182922 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Touch Medical Media |
record_format | MEDLINE/PubMed |
spelling | pubmed-61829222018-10-22 Updates in Diagnosis and Treatment of Acromegaly Zahr, Roula Fleseriu, Maria Eur Endocrinol Pituitary Acromegaly is a rare disease, caused largely by a growth hormone (GH) pituitary adenoma. Incidence is higher than previously thought. Due to increased morbidity and mortality, if not appropriately treated, early diagnosis efforts are essential. Screening is recommended for all patients with clinical features of GH excess. There is increased knowledge that classical diagnostic criteria no longer apply to all, and some patients can have GH excess with normal GH response to glucose. Treatment is multifactorial and personalised therapy is advised. Touch Medical Media 2018-09 2018-09-10 /pmc/articles/PMC6182922/ /pubmed/30349595 http://dx.doi.org/10.17925/EE.2018.14.2.57 Text en © The Author(s) 2018 http://creativecommons.org/licenses/by-nc/3.0/ This article is published under the Creative Commons Attribution Noncommercial License, which permits any non-commercial use, distribution, adaptation and reproduction provided the original author(s) and source are given appropriate credit. © The Authors 2018. Review Process: Double-blind peer review Authorship: All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship of this manuscript, take responsibility for the integrity of the work as a whole, and have given final approval to the version to be published. |
spellingShingle | Pituitary Zahr, Roula Fleseriu, Maria Updates in Diagnosis and Treatment of Acromegaly |
title | Updates in Diagnosis and Treatment of Acromegaly |
title_full | Updates in Diagnosis and Treatment of Acromegaly |
title_fullStr | Updates in Diagnosis and Treatment of Acromegaly |
title_full_unstemmed | Updates in Diagnosis and Treatment of Acromegaly |
title_short | Updates in Diagnosis and Treatment of Acromegaly |
title_sort | updates in diagnosis and treatment of acromegaly |
topic | Pituitary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182922/ https://www.ncbi.nlm.nih.gov/pubmed/30349595 http://dx.doi.org/10.17925/EE.2018.14.2.57 |
work_keys_str_mv | AT zahrroula updatesindiagnosisandtreatmentofacromegaly AT fleseriumaria updatesindiagnosisandtreatmentofacromegaly |